Cellectis (CLLS) Dividends Paid - Common Growth (1y) (2016 - 2026)
Cellectis (CLLS) Dividends Paid - Common Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.54% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -10.39% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Cellectis | 306.61 Mn | 120.95 Mn | - | -72.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -72.70% |
| Sep 30, 2025 | -175.32% |
| Jun 30, 2025 | -360.16% |
| Mar 31, 2025 | 3.79% |
| Sep 30, 2024 | 158.99% |
| Jun 30, 2024 | 2,301.94% |
| Mar 31, 2024 | 43.71% |
| Sep 30, 2023 | 46.44% |
| Jun 30, 2023 | 95.34% |
| Mar 31, 2023 | -44.75% |
| Sep 30, 2022 | 15.26% |
| Jun 30, 2022 | -162.37% |
| Mar 31, 2022 | -25.35% |
| Sep 30, 2021 | -16,411.74% |
| Jun 30, 2021 | 254.30% |
| Mar 31, 2021 | -27.75% |
| Sep 30, 2020 | 100.42% |
| Jun 30, 2020 | -7.89% |
| Mar 31, 2020 | -31.87% |
| Sep 30, 2019 | -1,294.78% |